US 9845512
Screening assay employing Dex and GDF8
granted A61KA61K31/573A61K38/1841
Quick answer
US patent 9845512 (Screening assay employing Dex and GDF8) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/573, A61K38/1841, A61K45/06, A61P